HeartSciences Inc.

HeartSciences Inc. (HSCS) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, but low signal in this timeframe does not indicate low forward risk. A micro-cap medical device company faces structural pressures—dilution risk, financing history, and AI-dependent product claims—that require deeper context. The full $49 Report pulls 12 months of SEC filings, quantifies dilution risk score, maps financing cycles, and flags AI risk signals tied to regulatory exposure. The full $49 Report adds quantified dilution trajectory, 8-K filing context, and AI product-claim risk signals that shape real downside scenarios.